Merck & Co (MRK) Sees Q1 EPS Below the Street on Venezuelan Currency Devaluation

February 13, 2013 9:06 AM EST Send to a Friend
Merck & Co., Inc. (NYSE: MRK) sees Q1 EPS of $0.76-$.78, following its preliminary assessment of the impact of the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login